Notch1 诱导肺泡上皮表面活性物质加工缺陷并促进肺纤维化
本研究探讨 Notch1 在特发性肺纤维化(IPF)中对 II 型肺泡上皮细胞(AEC2)命运的影响。研究发现 IPF 患者 AEC2 中表面活性蛋白 B/C 加工缺陷,与 Napsin A 缺失相关;Notch1 信号早期激活,抑制 AEC2 分化并促进增殖和纤维化,抑制 Notch 信号可逆转纤维化。
要点
- IPF 中 AEC2 表面活性蛋白 B/C 加工缺陷导致表面张力增高和内质网应激。
- Notch1 信号在 IPF 早期激活,抑制 AEC2 分化并促进增殖和纤维化。
- 抑制 Notch 信号可改善 IPF 肺切片中 AEC2 表面活性物质加工能力并逆转纤维化。
核心结论
- Notch1 是 IPF 中 AEC2 命运的核心调节因子,诱导上皮增殖、Napsin A 缺失和表面活性蛋白前体加工缺陷,并促进纤维增殖。
研究设计与样本
- 研究采用微阵列分析、激酶组分析、流式细胞术、免疫荧光、Western blot、定量 PCR 及增殖和表面活性分析,在体外(AEC2 细胞系、原代小鼠/人 AEC2)、离体(人 IPF 来源精准切割肺切片)和体内(博来霉素和胃蛋白酶抑制剂应用、Notch1 胞内域过表达)进行。
主要发现
- IPF 的 AEC2 中存在广泛的 SP-B 和 SP-C 加工缺陷,由 Napsin A 缺失引起,导致肺泡内表面张力增加、肺泡塌陷并诱导 AEC2 内质网应激。
- 体内药理学抑制 Napsin A 可导致 AEC2 损伤和明显的肺纤维化。
- Notch1 信号在 IPF 早期即已激活,通过抑制分化(减少板层体区室、降低加工疏水性 SP 的能力)和引起上皮增殖增加及肺纤维化发展来决定 AEC2 命运,推测通过改变 AEC2 中的 JAK/Stat 信号传导。
- 在 IPF 来源的精准切割肺切片中抑制 Notch 信号可改善 AEC2 的表面活性物质加工能力并逆转纤维化。
临床怎么用
- Notch1 信号通路可能作为 IPF 的潜在治疗靶点,抑制 Notch 信号或可改善 AEC2 功能并逆转纤维化。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Rationale: Although type II alveolar epithelial cells (AEC2s) are chronically injured in idiopathic pulmonary fibrosis (IPF), they contribute to epithelial regeneration in IPF. Objectives: We hypothesized that Notch signaling may contribute to AEC2 proliferation, dedifferentiation characterized by loss of surfactant processing machinery, and lung fibrosis in IPF. Methods: We applied microarray analysis, kinome profiling, flow cytometry, immunofluorescence analysis, western blotting, quantitative PCR, and proliferation and surface activity analysis to study epithelial differentiation, proliferation, and matrix deposition in vitro (AEC2 lines, primary murine/human AEC2s), ex vivo (human IPF-derived precision-cut lung slices), and in vivo (bleomycin and pepstatin application, Notch1 [Notch receptor 1] intracellular domain overexpression). Measurements and Main Results: We document here extensive SP-B and -C (surfactant protein-B and -C) processing defects in IPF AEC2s, due to loss of Napsin A, resulting in increased intra-alveolar surface tension and alveolar collapse and induction of endoplasmic reticulum stress in AEC2s. In vivo pharmacological inhibition of Napsin A results in the development of AEC2 injury and overt lung fibrosis. We also demonstrate that Notch1 signaling is already activated early in IPF and determines AEC2 fate by inhibiting differentiation (reduced lamellar body compartment, reduced capacity to process hydrophobic SP) and by causing increased epithelial proliferation and development of lung fibrosis, putatively via altered JAK (Janus kinase)/Stat (signal transducer and activator of transcription) signaling in AEC2s. Conversely, inhibition of Notch signaling in IPF-derived precision-cut lung slices improved the surfactant processing capacity of AEC2s and reversed fibrosis. Conclusions: Notch1 is a central regulator of AEC2 fate in IPF. It induces alveolar epithelial proliferation and loss of Napsin A and of surfactant proprotein processing, and it contributes to fibroproliferation.
引用
- Wasnick R, Korfei M, Piskulak K, et al. Notch1 Induces Defective Epithelial Surfactant Processing and Pulmonary Fibrosis. Am J Respir Crit Care Med. 2023. PMID: 36047984. doi:10.1164/rccm.202105-1284OC
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。